Christopher P. Lowe - 24 Aug 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Director
Signature
/s/ Christopher P. Lowe
Issuer symbol
VINC
Transactions as of
24 Aug 2022
Net transactions value
+$49,438
Form type
4
Filing time
26 Aug 2022, 16:06:10 UTC
Previous filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VINC Common Stock Purchase $30,299 +18,400 +184% $1.65 28,400 24 Aug 2022 Direct F1
transaction VINC Common Stock Purchase $19,139 +11,600 +41% $1.65 40,000 25 Aug 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average purchase price. Actual purchase prices ranged from $1.638 to $1.649 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
F2 Represents a weighted average purchase price. Actual purchase prices ranged from $1.6499 to $1.65 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.